Tag: "iii" at medical news

Can There Be A Diabetes Type III?

A recent study is staking a claim that there may be evidence of insulin being produced in the brain that may be a type of //diabetes. In the cases where there are evidence of insulin and related proteins being produced by the brain, the levels of both are related to Alzheimer's disease. ....The findings, which came out in the march, issue of the Journal of Alzheimer's Disease, say that insulin i...

Arsenic May Have Been Responsible For The Madness Of King George III Of England

An interesting study from hair of King George III reveals that he may// have been consuming Arsenic and this lead to his unusually severe and prolonged bouts of madness. ....Lancet has published this report this week and at last has been able to throw light on the reason for the madness of the famous English King George III. The study reports to have found high concentrations of arsenic in a s...

Study Unveils New Insight To The Madness Of King George III

Researchers from Dana-Farber Cancer Institute had discovered a new molecular explanation for the episodic attacks of irrational and demented behavior in the disease called porphyria, the disease that was probably behind the // madness of king George III. .. ..The Dana-Farber scientists say in a report featured on the cover of the August 26 issue of the journal Cell that the nutritional component...

Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine

Antigenics Pharmaceuticals is to start its Phase III cancer vaccine trial against Melanoma which is a type of skin cancer. Oncophage is the new skin cancer vaccine developed by Antigenics.// The vaccine trial of Oncophage which was conducted in 322 patients failed to meet the required statistically significance results compared to prolongation in survival and the vaccine was not shown to have any...

NIH Announces Phase III Clinical Trial of Creatine for Parkinson's Disease

The NIH National Institute of Neurological Disorders and Stroke (NINDS) today is launching a large-scale clinical trial to learn if the nutritional supplement creatine// can slow the progression of Parkinson's disease (PD). While creatine is not an approved therapy for PD or any other condition, it is widely thought to improve exercise performance. The potential benefit of creatine for PD was ide...

Overuse of Popular Console can Cause 'Wiiitis' in Gamers

Nintendo's innovative game machine has spawned rave reviews and monster sales by allowing players to use natural motions rather than tiny thumb movements to control the action in video games. ......But the hit gaming system may also have a downside - a newly diagnosed ailment called Wiiitis (pronounced Wee-i-tis), according to a report published Thursday in the New England Journal of Medicine....

ENDEAVOR III Trial Reports Key Findings on New-generation Stent

New data reported at the 30th Annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions (SCAI), May 912, 2007, in Orlando, FL, will offer clues to the fate of a new-generation drug-eluting stent that is vying for a place in the treatment of coronary artery disease. ......The Endeavor III trial randomly assigned 436 patients treated at 30 medical centers in the U...

Avicena to Advance Huntington's Disease Clinical Program into Phase III

Avicena Group, Inc. (OTC Bulletin Board: AVGO), a late stage biotechnology company that develops central nervous system therapeutics for neurodegenerative diseases, announced today the selection of the optimal dose of HD-02, its novel drug candidate for the treatment of Huntington's Disease. ...This dose was determined in an open-label dose escalation study, led by Dr. Steven Hersch and Dr. Dia...

Novagali Pharma Presents Phase III Clinical Trial of Vekacia(R) for Vernal Keratoconjunctivitis

Novagali Pharma, an emerging pharmaceutical company specialized in ophthalmology presents positive results of its pivotal phase III clinical trial positive results from the Phase III clinical study of Vekacia(R) in children suffering from Vernal Keratoconjunctivitis (VKC) at the XIV Afro-Asian Congress of ophthalmology (AACO) held from June 20 to 25 2007 in Marrakech (Morocco). ......VKC is a s...

Roches Arthritis Drug Successful in III Stage Trail

Roche Holding AG says that arthritis drug Actemra has proved successful in a phase III clinical study. Actemra helps relieve symptoms of rheumatoid arthritis in difficult-to-treat patients in a clinical study thus bringing it closer to regulatory approval. ...The Radiate study was conducted over 24 weeks with 498 patients with difficult-to-treat RA. Actemra was given in combination with a standa...

Genzyme Announces First Phase III Study of Tolevamer in Diarrhea Patients

Genzyme Corp. announced top-line data from the first of two Phase 3 clinical studies to assess the safety and efficacy of tolevamer liquid, an investigational, non-antibiotic , polymer therapy for patients with Clostridium difficile associated diarrhea (CDAD). The second Phase 3 study of tolevamer liquid is fully enrolled and results are expected later this year. ......In this first Phase 3 study...